Tender detail

Tender for Ustekinumab medicinal products 103/2026

Summary

The tender concerns the supply of medicinal products containing Ustekinumab in two lots. The estimated total value is EUR 7,277,955, and the planned duration of each lot is 24 months. The tender submission deadline is 29 October 2026 at 13:00. Price is the only award criterion. Tenders must be submitted electronically; variants are not permitted, but bidders may submit for both lots. The tender must remain valid for six months.

Reference number
631834-2026
Buyer
Υπουργείο Υγείας
Country
Cyprus (CYP)
Procedure
Open procedure
CPV
33652000 Antineoplastic and immunomodulating agents
Deadline
2026-10-29
Status
Evaluation
Contract subject
Supplies
Estimated value
7 277 955,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.